• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞:前景与局限

Stem cells: promises versus limitations.

作者信息

Choumerianou Despoina M, Dimitriou Helen, Kalmanti Maria

机构信息

Department of Pediatric Hematology-Oncology, University Hospital of Heraklion, University of Crete, Heraklion, Crete, Greece.

出版信息

Tissue Eng Part B Rev. 2008 Mar;14(1):53-60. doi: 10.1089/teb.2007.0216.

DOI:10.1089/teb.2007.0216
PMID:18454634
Abstract

Stem cells are the self-renewing progenitors of several body tissues and are classified according to their origin and their ability to differentiate. Current research focuses on the potential uses of stem cells in medicine and how they can provide effective treatment for a range of diseases. This approach has resulted in the field of medical practice called regenerative medicine. To attain the promises of regenerative medicine, it is necessary to fully understand the biology and properties of stem cells, achieve their successful differentiation into functional tissues, overcome the barriers related to immune responses after administration, and assess any oncogenic properties that limit their use. The availability of human stem cells not only raises hope for cell replacement therapies, but also provides a system for understanding the mechanisms of embryonic development and disease progression. Nevertheless, it raises ethical concerns that need to be addressed before the use of stem cells in clinical practice.

摘要

干细胞是多种身体组织的自我更新祖细胞,并根据其来源和分化能力进行分类。当前的研究集中在干细胞在医学中的潜在用途以及它们如何为一系列疾病提供有效治疗。这种方法催生了被称为再生医学的医学实践领域。为了实现再生医学的前景,有必要充分了解干细胞的生物学特性和性质,实现它们成功分化为功能组织,克服给药后与免疫反应相关的障碍,并评估限制其使用的任何致癌特性。人类干细胞的可用性不仅为细胞替代疗法带来了希望,还提供了一个理解胚胎发育和疾病进展机制的系统。然而,在临床实践中使用干细胞之前,这也引发了一些需要解决的伦理问题。

相似文献

1
Stem cells: promises versus limitations.干细胞:前景与局限
Tissue Eng Part B Rev. 2008 Mar;14(1):53-60. doi: 10.1089/teb.2007.0216.
2
Adult stem cells: hopes and hypes of regenerative medicine.成体干细胞:再生医学的希望与炒作
Acta Biochim Pol. 2015;62(3):329-37. doi: 10.18388/abp.2015_1023. Epub 2015 Jul 22.
3
Chemical control of stem cell fate and developmental potential.化学调控干细胞命运和发育潜能。
Angew Chem Int Ed Engl. 2011 Jan 3;50(1):200-42. doi: 10.1002/anie.201004284.
4
Human embryonic stem cells: origins, characteristics and potential for regenerative therapy.人类胚胎干细胞:起源、特征及再生治疗潜力
Transfus Med. 2008 Feb;18(1):1-12. doi: 10.1111/j.1365-3148.2007.00807.x.
5
Very small embryonic-like cells in the mirror of regenerative medicine.再生医学视角下的极小型胚胎样细胞。
J Stem Cells. 2014;9(1):1-16.
6
Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challenges.基础科学领域的创新:干细胞及其在小儿心力衰竭治疗中的作用——机遇与挑战
Cardiol Young. 2009 Nov;19 Suppl 2:74-84. doi: 10.1017/S104795110999165X.
7
Stem cells in genetic myelin disorders.遗传性髓鞘疾病中的干细胞。
Regen Med. 2010 May;5(3):425-39. doi: 10.2217/rme.10.10.
8
Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine.简明综述:脂肪来源干细胞作为未来再生医学的一种新型工具。
Stem Cells. 2012 May;30(5):804-10. doi: 10.1002/stem.1076.
9
Stem cells.干细胞。
Plast Reconstr Surg. 2010 Oct;126(4):1163-1171. doi: 10.1097/PRS.0b013e3181ea42bb.
10
In vitro differentiation potential of human embryonic versus adult stem cells.人类胚胎和成体干细胞的体外分化潜能。
Regen Med. 2010 May;5(3):365-79. doi: 10.2217/rme.10.20.

引用本文的文献

1
Stem Cell Therapy in Ischemic Heart Failure.缺血性心力衰竭的干细胞治疗
Am J Cardiovasc Drugs. 2025 Jun 27. doi: 10.1007/s40256-025-00741-0.
2
Current Challenges in the Development of Platelet-Rich Plasma-Based Therapies.富血小板血浆疗法发展面临的挑战。
Biomed Res Int. 2024 Aug 9;2024:6444120. doi: 10.1155/2024/6444120. eCollection 2024.
3
Stem Cells and Acellular Preparations in Bone Regeneration/Fracture Healing: Current Therapies and Future Directions.干细胞和无细胞制剂在骨再生/骨折愈合中的应用:当前治疗方法和未来方向。
Cells. 2024 Jun 17;13(12):1045. doi: 10.3390/cells13121045.
4
Bioactive fiber-reinforced hydrogel to tailor cell microenvironment for structural and functional regeneration of myotendinous junction.生物活性纤维增强水凝胶用于定制细胞微环境以实现肌腱-肌连接的结构和功能再生
Sci Adv. 2024 Apr 26;10(17):eadm7164. doi: 10.1126/sciadv.adm7164. Epub 2024 Apr 24.
5
Gens PSD-95 and GSK-3β expression improved by hair follicular stem cells-conditioned medium enhances synaptic transmission and cognitive abilities in the rat model of vascular dementia.毛囊干细胞条件培养基改善的Gens PSD-95和GSK-3β表达增强血管性痴呆大鼠模型的突触传递和认知能力。
Brain Behav. 2024 Jan;14(1):e3351. doi: 10.1002/brb3.3351.
6
Photoacoustic Monitoring of Stem Cell Location and Apoptosis with Caspase-3-Responsive Nanosensors.基于 Caspase-3 响应性纳米传感器的干细胞定位与凋亡的光声监测
ACS Nano. 2023 Sep 26;17(18):17931-17945. doi: 10.1021/acsnano.3c04161. Epub 2023 Sep 13.
7
Biological effect of bone marrow mesenchymal stem cell- derived extracellular vesicles on the structure of alveolar bone in rats with glucocorticoid-induced osteoporosis.骨髓间充质干细胞衍生的细胞外囊泡对糖皮质激素诱导骨质疏松症大鼠肺泡骨结构的生物学效应。
BMC Musculoskelet Disord. 2023 Mar 17;24(1):205. doi: 10.1186/s12891-023-06276-2.
8
The BE (2)-M17 cell line has a better dopaminergic phenotype than the traditionally used for Parkinson´s research SH-SY5Y, which is mostly serotonergic.BE(2)-M17细胞系比传统用于帕金森病研究的SH-SY5Y细胞系具有更好的多巴胺能表型,SH-SY5Y细胞系主要是血清素能的。
IBRO Neurosci Rep. 2022 Nov 20;13:543-551. doi: 10.1016/j.ibneur.2022.11.007. eCollection 2022 Dec.
9
Dental-derived cells for regenerative medicine: stem cells, cell reprogramming, and transdifferentiation.用于再生医学的牙源细胞:干细胞、细胞重编程和转分化
J Periodontal Implant Sci. 2022 Dec;52(6):437-454. doi: 10.5051/jpis.2103760188. Epub 2022 May 18.
10
Therapies Based on Adipose-Derived Stem Cells for Lower Urinary Tract Dysfunction: A Narrative Review.基于脂肪来源干细胞治疗下尿路功能障碍的叙述性综述
Pharmaceutics. 2022 Oct 19;14(10):2229. doi: 10.3390/pharmaceutics14102229.